SOPHARMA (SPH) komunikat - Sopharma monthly December 2015

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		4	/	2016
Date of issue:	2016-01-11
Short name of the issuer
SOPHARMA AD
Subject
Sopharma monthly December 2015
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
Sopharma AD notifies that for December 2015 the Company recorded an increase of sales revenues of 8% compared to the same month of 2014, including 16% increase in domestic sales and 32% increase in export sales. The increase in export sales is mainly due to an increase in sales on the Russian market by 45%. The management has planned to sustain the export activity in the months January and December 2016, as well as to improve the rhythm of sales in Russia in the summer months. Our expectations are for a better performance of our products, if the current macroeconomic environment remain stable. The expected increase for January 2016 is also high, mainly due to the low baseline from 2015, when due to the volatility of the Russian ruble the sales on the Russian market were temporarily stopped. Sales revenues for 2015 decreased by 14% compared to the same period of 2014, including 0.3% increase of domestic sales and a 20% decrease of export sales.
Annexes
File			Description
			Sopharma monthly December 2015

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2016-01-11	Ognian Donev	Executive director

Konta:	Konta osobiste Konta młodzieżowe Konta firmowe Konta walutowe
Kredyty:	Kredyty gotówkowe Kredyty mieszkaniowe Kredyty z dopłatą Kredyty dla firm

Sopharma monthly December 2015